GR1008186B - Φαρμακευτικο σκευασμα περιεχον ενα ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου - Google Patents

Φαρμακευτικο σκευασμα περιεχον ενα ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου

Info

Publication number
GR1008186B
GR1008186B GR20130100249A GR20130100249A GR1008186B GR 1008186 B GR1008186 B GR 1008186B GR 20130100249 A GR20130100249 A GR 20130100249A GR 20130100249 A GR20130100249 A GR 20130100249A GR 1008186 B GR1008186 B GR 1008186B
Authority
GR
Greece
Prior art keywords
preparation
pharmaceutical composition
atypical antipsychotic
antipsychotic agent
relates
Prior art date
Application number
GR20130100249A
Other languages
English (en)
Inventor
Ευθυμιος Χρηστου Κουτρης
Ιωαννα Χρηστου Κουτρη
Αναστασια Λεωνιδα Καλασκανη
Βασιλικη Χρηστου Σαμαρα
Ανδρεας Κωνσταντινου Κακουρης
Ευαγγελος Ανδρεα Καραβας
Γεωργιος Θεμιστοκλη Γκοτζαμανης
Original Assignee
"Φαρματεν Α.Β.Ε.Ε.",
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Φαρματεν Α.Β.Ε.Ε.", filed Critical "Φαρματεν Α.Β.Ε.Ε.",
Priority to GR20130100249A priority Critical patent/GR1008186B/el
Priority to EP14722990.0A priority patent/EP2988727B1/en
Priority to PCT/EP2014/001040 priority patent/WO2014173515A1/en
Priority to ES14722990T priority patent/ES2735009T3/es
Publication of GR1008186B publication Critical patent/GR1008186B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αφορά διασπειρόμενο σκεύασμα περιέχον έναν άτυπο αντιψυχωσικό παράγοντα, όπως Αριπιπραζόλη ή κάποιο φαρμακευτικά αποδεκτό άλας αυτής, ως δραστική ουσία καθώς και δραστική ποσότητα ενός τουλάχιστον φαρμακευτικά αποδεκτού υδατοδιαλυτού και ενός τουλάχιστον μη υδατοδιαλυτού αραιωτικού μέσου. Επίσης, η εφεύρεση αφορά και τη μέθοδο παρασκευής αυτού.
GR20130100249A 2013-04-22 2013-04-22 Φαρμακευτικο σκευασμα περιεχον ενα ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου GR1008186B (el)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GR20130100249A GR1008186B (el) 2013-04-22 2013-04-22 Φαρμακευτικο σκευασμα περιεχον ενα ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου
EP14722990.0A EP2988727B1 (en) 2013-04-22 2014-04-17 Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof
PCT/EP2014/001040 WO2014173515A1 (en) 2013-04-22 2014-04-17 Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof
ES14722990T ES2735009T3 (es) 2013-04-22 2014-04-17 Composición farmacéutica que comprende un agente antipsicótico atípico y un método para su preparación

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20130100249A GR1008186B (el) 2013-04-22 2013-04-22 Φαρμακευτικο σκευασμα περιεχον ενα ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου

Publications (1)

Publication Number Publication Date
GR1008186B true GR1008186B (el) 2014-05-08

Family

ID=50687440

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20130100249A GR1008186B (el) 2013-04-22 2013-04-22 Φαρμακευτικο σκευασμα περιεχον ενα ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου

Country Status (4)

Country Link
EP (1) EP2988727B1 (el)
ES (1) ES2735009T3 (el)
GR (1) GR1008186B (el)
WO (1) WO2014173515A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1008442B (el) * 2014-01-16 2015-03-05 "Φαρματεν Α.Β.Ε.Ε.", Φαρμακευτικο σκευασμα περιεχον αριπιπραζολη ή αλας αυτης
TR201617675A2 (tr) * 2016-12-02 2018-06-21 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Ari̇pi̇prazole monohi̇drat formülasyonlarinin ağizda dağilan tablet formu
CN108938578A (zh) * 2017-05-25 2018-12-07 万全万特制药（厦门）有限公司 阿立哌唑分散片及其制备方法
CN117281784B (zh) * 2023-11-24 2024-02-27 山东则正医药技术有限公司 一种阿立哌唑注射剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004017897A2 (en) 2002-08-20 2004-03-04 Bristol-Myers Squibb Company Aripiprazole complex formulation and method
EP1933814A2 (en) 2005-09-15 2008-06-25 Elan Pharma International Limited Nanoparticulate aripiprazole formulations
US7811604B1 (en) * 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
AU2007232098A1 (en) * 2006-03-31 2007-10-11 Rubicon Research Private Limited Directly compressible composite for orally disintegrating tablets
TR200604349A2 (tr) 2006-08-15 2008-03-21 NOBEL İLAÇ SANAYii VE TiCARET A.Ş. Aripiprazol içeren farmasötik bileşimler
CN102451162A (zh) * 2010-10-21 2012-05-16 重庆市力扬医药开发有限公司 经口腔粘膜吸收的奥氮平药物
WO2013100878A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Pharmaceutical formulations comprising aripiprazole
DK2822541T3 (da) * 2012-09-10 2019-01-02 Pharmathen Sa Farmaceutisk sammensætning omfattende et atypisk antipsykotisk middel og fremgangsmåde til fremstilling deraf

Also Published As

Publication number Publication date
ES2735009T3 (es) 2019-12-13
WO2014173515A1 (en) 2014-10-30
EP2988727A1 (en) 2016-03-02
EP2988727B1 (en) 2019-05-01

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
EP3283065A4 (en) Methods for formulating orally ingestible compositions comprising lipophilic active agents
MD4650B1 (ro) Derivaţi de chinazolină utilizaţi în tratamentul HIV
PH12016500170A1 (en) Formulation of syk inhibitors
PH12016501122A1 (en) Delayed release compositions of linaclotide
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
MY180526A (en) Pharmaceutical composition of s-ketamine hydrochloride
MY191332A (en) Pharmaceutical composition of s-ketamine hydrochloride
IN2014DN10670A (el)
PH12018500446A1 (en) Pyridinone dicarboxamide for use as bromodomain inhibitors
WO2014155300A3 (en) Substitued pyrimidine amine derivatives as tak-1 inhibitors
EP2995304A4 (en) Composition for preventing or treating symptoms of menopause comprising soybean extract comprising coumestrol as an active ingredient
EP3231436A4 (en) Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient
IN2013MU03641A (el)
WO2014033526A9 (en) Pharmaceutical compositions of etoricoxib
MX2018004304A (es) DERIVADOS DE QUINOXALINA Y PIRIDOPRAZINA COMO INHIBIDORES DE PI3Kß.
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
MX2018005004A (es) Compuestos de indazol substituidos como inhibidores de rorgammat y sus usos.
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
IN2014CH00840A (el)
GR1008186B (el) Φαρμακευτικο σκευασμα περιεχον ενα ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου
PH12016502568A1 (en) Novel heterocyclic compound
MX2017008074A (es) DERIVADOS DE IMIDAZOPIRIDAZINA COMO INHIBIDORES DE FOSFOINOSITIDA-3-QUINASAS BETA (PI3Kß).
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
MX2017002544A (es) Derivados de isoquinolinona utiles en el tratamiento contra el cancer.

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20140625